Skip to content

A study of the effect of LPS-containing foods on nasal eye allergic reactions.

A Parallel Group Randomized Double-Blind Trial in Healthy Subjects Study on the Effect of 8 Weeks of Continuous Intake of Food Containing LPS on Allergic Reactions in the Nasal Eye - A Double-Blind Study on the Effects of 8-Week Consumption of Food Products Containing LPS on Nasal Eye Allergic Reactions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049974
Enrollment
60
Registered
2023-01-06
Start date
2023-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

Sponsors

Innate Immune Network
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Persons in the healthy range between 20 and 65 years of age who have experienced nasal eye allergic reactions. 2) Patients with nasal and eye symptoms according to the "Japanese Allergic Rhinitis Standard Quality of Life Questionnaire" or with specific IgE (both house dust and cedar pollen) of 0.35 UA/mL or higher. 3) The applicant must have received an explanation of the study prior to participating in the study, understand the details of the study, and agree to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Currently taking medication or visiting a hospital for the treatment of any disease. 2) Currently under the supervision of a physician for exercise or diet therapy. 3) Persons who are at risk of developing allergies to the test food. 4) Pregnant women and nursing mothers. 5) Smokers. 6) Use of any medication during the 4 weeks prior to the start of the study that the study physician determines will affect participation in the study. 7) Inability to stop eating foods during the study period that the study physician determines may affect participation in the study. 8) Those who are participating or will participate in other clinical trials. 9) Persons who have donated at least 400 mL of blood at least 3 months prior to the date of consent or at least 200 mL of blood at least 1 month prior to the date of consent. 10) Any other person who has been judged by the investigator to be ineligible to participate in the study.

Design outcomes

Primary

MeasureTime frame
Japan Allergic Rhinitis Standard Quality of Life Questionnaire (JRQLQ)

Secondary

MeasureTime frame
1)Nonspecific IgE, Specific IgE (house dust, cedar pollen) 2) Eosinophil count 3)Hematology examination 4)Biochemical examination 5)Height, Weight, BMI

Countries

Japan

Contacts

Public ContactYuko Nakamoto

Innate Immune Network Secretariat

npolsinlsin@lsin.org087-813-9201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026